Since androgen receptor (AR) expression is less prevalent in TNBC than other breast cancer subtypes and AR regulates multiple molecular pathways affecting tumorigenesis and disease progression, the molecular classification of TNBC according to AR expression has gained interest. This evidence concerns the gene AR and breast carcinoma.